Is Shree Ganesh Remedies Ltd (540737) a good quality company?

Past 10 year's financial track record analysis by Moneyworks4me indicates that Shree Ganesh Remedies Ltd is a average quality company .

Is Shree Ganesh Remedies Ltd (540737) undervalued or overvalued?

The key valuation ratios of Shree Ganesh Remedies Ltd's currently when compared to its past seem to suggest it is in the Somewhat overvalued zone .

What is Shree Ganesh Remedies Ltd (540737) share price return in the past 10 years?

Data is not available for this company

Is Shree Ganesh Remedies Ltd (540737) a good buy now?

The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of Shree Ganesh Remedies Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.

What is the share price of Shree Ganesh Remedies Ltd (540737)?

Company share prices are keep on changing according to the market conditions. The current trading price of Shree Ganesh Remedies Ltd (540737) on 17-Apr-2026 16:59:59 at 16:59 is 533.90.

What is the market cap of Shree Ganesh Remedies Ltd (540737)?

Market capitalization is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 17-Apr-2026 at 16:59, the market cap of Shree Ganesh Remedies stood at Rs. 685.40 Cr.

What is the P/E ratio of Shree Ganesh Remedies?

The latest standalone P/E ratio of Shree Ganesh Remedies as of 17-Apr-2026 is 37.87.

What is the P/B ratio of Shree Ganesh Remedies Ltd (540737)?

The latest standalone P/B ratio of Shree Ganesh Remedies Ltd (540737) as of 17-Apr-2026 is 4.38.

What is the 52-week high and low of Shree Ganesh Remedies Ltd (540737)?

The 52-week high of Shree Ganesh Remedies Ltd (540737) is Rs. 828.00 and the 52-week low is Rs. 381.10.

What is the TTM revenue of Shree Ganesh Remedies Ltd (540737)?

The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Shree Ganesh Remedies is Rs. 100.52 (Cr.).

Shree Ganesh Remedies Ltd (540737) Share Analysis – Quality, Pipeline & Valuation Zone & DeciZen Rating

Name: Shree Ganesh Remedies Ltd (540737)
Brand: Shree Ganesh Remedies

10 Year X-Ray :

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Value Creation ⓘ

Value Creation Index Colour Code Guide ⓘ

	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25	TTM
ROCE % ⓘ	12.4%	26.2%	27.7%	27%	32.6%	27.5%	32.5%	22.5%	27.8%	19.5%	-
Value Creation Index ⓘ	-0.1	0.9	1.0	0.9	1.3	1.0	1.3	0.6	1.0	0.4	-
Growth Parameters ⓘ Growth Parameters Colour Code Guide ⓘ
Sales ⓘ	15.5	19.9	27.3	35.3	58.4	49.1	71.3	91.4	126	109	101
Sales YoY Gr.	-	28%	37.3%	29.5%	65.5%	-16%	45.3%	28.2%	37.8%	-13.7%	-
Adj EPS ⓘ	1.1	2.8	3	4.7	6.7	7.5	9.6	12.4	19.5	17	14.1
YoY Gr.	-	167.9%	5.6%	57.7%	41.9%	11.9%	27.3%	29.9%	56.6%	-12.4%	-
BVPS (₹) ⓘ	15.7	18.6	23.7	28	34.8	41.4	50.9	69.7	95.1	113.1	122
Adj Net Profit ⓘ	1	2.5	3.6	5.7	8.1	9.1	11.6	16	26.6	21.9	18
Cash Flow from Ops. ⓘ	0	0	-0.9	-5.2	3.9	3.3	13.4	17.1	30.5	30.7	-
Debt/CF from Ops. ⓘ	0	0	-2.6	-0.1	0.6	0.1	0	1.9	1.2	1.3	-

CAGR ⓘ

CAGR Colour Code Guide ⓘ

	9 Years	5 Years	3 Years	1 Years
Sales ⓘ	24.1%	13.2%	15.1%	-13.7%
Adj EPS ⓘ	36.2%	20.5%	21.3%	-12.4%
BVPSⓘ	24.5%	26.6%	30.5%	19%
Share Price	-	17.2%	19.9%	-26.5%

Key Financial Parameters ⓘ

Performance Ratio Colour Code Guide ⓘ

	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25	TTM
Return on Equity % ⓘ	7	16.6	16.1	18.3	21.4	19.7	20.7	21.5	25.4	16.4	12
Op. Profit Mgn % ⓘ	12.5	20.5	19	24.8	18.7	27.8	25.2	26.9	33.2	36.1	33.4
Net Profit Mgn % ⓘ	6.1	12.7	13.3	16.2	13.9	18.5	16.2	17.5	21.1	20.2	18
Debt to Equity ⓘ	0	0	0.1	0	0.1	0	0	0.4	0.3	0.3	-
Working Cap Days ⓘ	234	223	207	200	153	224	194	197	164	209	134
Cash Conv. Cycle ⓘ	164	134	97	96	88	125	93	90	83	113	104

Recent Performance Summary

Sales growth is growing at healthy rate in last 3 years 15.06%

Net Profit is growing at healthy rate in last 3 years 21.25%

Return on Equity has declined versus last 3 years average to 12.00%

Sales growth is not so good in last 4 quarters at -15.80%

	Standalone	Consolidated
TTM EPS (₹)	14.1	14.1
TTM Sales (₹ Cr.)	101	101
BVPS (₹) ⓘ	122	122
Reserves (₹ Cr.) ⓘ	144	144
P/BV ⓘ	4.38	4.38
PE ⓘ	37.87	37.91

From the Market
52 Week Low / High (₹)	381.10 / 828.00
All Time Low / High (₹)	22.07 / 950.05
Market Cap (₹ Cr.)	685
Equity (₹ Cr.)	12.8
Face Value (₹)	10
Industry PE ⓘ	42.1

PARTICULARS	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Sales	16	20	27	35	58	49	71	91	126	109
Operating Expenses ⓘ +	14	16	22	27	47	35	53	68	84	69
Manufacturing Costs	1	1	1	1	2	2	5	8	11	15
Material Costs	9	10	15	18	36	22	37	47	57	36
Employee Cost	1	1	2	2	2	2	3	6	8	10
Other Costs ⓘ	3	3	4	5	8	9	8	7	7	8
Operating Profit ⓘ	2	4	5	9	11	14	18	23	42	39
Operating Profit Margin (%)	12.4%	20.5%	19.0%	24.8%	18.7%	27.8%	25.1%	25.7%	33.2%	36.1%
Other Income ⓘ +	0	0	2	1	4	2	4	1	3	4
Exceptional Items ⓘ	0	0	0	0	0	0	0	0	0	0
Interest ⓘ	0	0	0	0	0	0	0	0	1	2
Depreciation ⓘ	1	1	1	1	2	3	3	4	6	10
Profit Before Tax ⓘ	2	4	6	9	13	13	18	20	38	31
Tax ⓘ	1	1	2	2	3	3	5	5	10	8
Profit After Tax	1	3	5	6	10	10	13	15	28	23
PAT Margin (%)	7.0%	13.3%	17.2%	17.7%	16.5%	19.9%	18.8%	16.6%	22.3%	21.3%
Adjusted EPS (₹)	1.2	3.0	3.9	5.2	8.0	8.1	11.1	12.1	21.9	18.0
Dividend Payout Ratio (%)	0%	0%	19%	18%	14%	18%	4%	4%	0%	0%

PARTICULARS	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Equity and Liabilities
Shareholders Fund +	14	16	29	34	42	50	62	87	122	145
Share Capital ⓘ	1	1	9	9	9	10	12	13	13	13
Reserves ⓘ	13	15	20	25	33	40	50	75	109	132
Debt +	0	0	2	1	2	0	0	32	30	29
Long Term Debt	0	0	0	0	0	0	0	30	29	29
Short Term Debt	0	0	2	0	2	0	0	2	1	0
Minority Interest	0	0	0	0	0	0	0	0	0	0
Trade Payables	1	2	2	4	4	6	9	15	8	6
Others Liabilities ⓘ	1	2	3	3	4	4	6	8	18	19
Total Liabilities ⓘ	16	21	36	41	52	61	77	143	178	200
Fixed Assets
Net Fixed Assets ⓘ +	4	4	6	14	16	19	27	58	81	95
Gross Block	9	9	12	21	25	30	42	77	105	128
Accumulated Depreciation	5	5	6	7	9	11	15	19	25	33
CWIP ⓘ	0	0	0	0	0	2	3	15	17	9
Investments ⓘ	0	0	4	4	7	3	0	0	5	18
Inventories	3	3	4	7	6	13	14	18	25	22
Trade Receivables	6	7	6	10	17	13	18	28	20	22
Cash Equivalents	1	3	9	1	2	3	4	12	16	10
Others Assets ⓘ	2	4	7	6	5	7	11	12	14	24
Total Assets ⓘ	16	21	36	41	52	61	77	143	178	200

PARTICULARS	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Cash Flow From Operating Activity ⓘ +	-1	-5	4	3	13	17	30	31
PBT ⓘ	6	9	13	13	18	20	38	31
Adjustment ⓘ	0	-0	-6	-8	-2	6	6	11
Changes in Working Capital ⓘ	-7	-14	-3	-2	2	-4	-5	-2
Tax Paid ⓘ	0	0	0	0	-4	-6	-8	-10
Cash Flow From Investing Activity ⓘ +	-3	-0	-3	-1	-12	-51	-33	-36
Capex	1	-0	-0	-0	-15	-49	-31	-23
Net Investments	-4	0	-3	-1	3	-2	-2	-13
Others ⓘ	0	0	0	0	0	0	-0	0
Cash Flow From Financing Activity ⓘ +	8	-0	-0	-1	-1	39	10	-1
Net Proceeds from Shares ⓘ	8	0	0	0	0	11	7	0
Net Proceeds from Borrowing ⓘ	0	0	0	0	-0	0	0	0
Interest Paid ⓘ	0	0	0	0	0	-0	-1	-2
Dividend Paid ⓘ	0	0	0	0	-2	-1	-1	0
Others ⓘ	-0	-0	-0	-1	1	28	4	1
Net Cash Flow ⓘ	4	-5	1	2	0	5	7	-6

PARTICULARS	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Ratios
ROE (%)	8.06	17.31	20.75	19.95	25.35	21.18	24.02	20.41	26.87	17.28
ROCE (%)	12.42	26.15	27.68	27.04	32.63	27.51	32.47	22.46	27.83	19.53
Asset Turnover Ratio	1	1.08	0.96	0.92	1.25	0.87	1.04	0.84	0.81	0.59
PAT to CFO Conversion(x)	0	0	-0.2	-0.83	0.4	0.3	1	1.13	1.07	1.35
Working Capital Days
Receivable Days	116	120	87	80	82	111	81	92	68	70
Inventory Days	75	54	48	56	38	68	67	63	61	77
Payable Days	39	58	52	56	40	83	77	96	75	72

Build a Stress-Tested Portfolio.

Our Sapphire Advisory uses the ABC Concept to ensure you never have to panic during a market correction.

Core Stocks

STABILITY

Booster Stocks

GROWTH

Amplifier Stocks

ASYMMETRY

● Conflict-Free ● SEBI Registered ● 15Y+ Track Record

Name of the IA registered with SEBI:	The Alchemists Ark Pvt. Ltd.
Logo:
Trade/Brand Name of IA:	MoneyWorks4Me Investment Advisers
Brand Logo:
SEBI Registration Number:	INA000013323 Validity – May 16, 2019 – Perpetual
Registration:	Non-Individual
BSE Enlistment No:	1187
Address:	B-101, Signet Corner Building, Balewadi Phata, Baner, Pune, Maharashtra 411045
Compliance officer Details:	Name: Shrikant Jagtap Email: shrikant.jagtap@moneyworks4me.com Telephone: +919860359463 Address: Same as IA
Grievance Officer Details:	Name: Mukta Vaze Email: mukta.vaze@moneyworks4me.com Telephone: +91 98609 19463 Address: Same as IA
Principal Officer Details:	Name: Atharva Bhide Email: atharva.bhide@moneyworks4me.com Telephone: +91 91758 99463 Address: Same as IA
Standard Warning:	Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Disclaimer:	Registration granted by SEBI, enlistment with exchange and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.

Shree Ganesh Remedies Ltd (540737) Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating

Shree Ganesh Remed. Share Price